OVERVIEW

Company Name

SEIKAGAKU CORPORATION

President

Ken  Mizutani

Establishment

June 2, 1947

Business activities

Manufacturing and sales of pharmaceuticals and medical devices specifically related to glycoconjugates.

Stock Exchange Listing

Tokyo Stock Exchange, First section

Number of Employees

744(Consolidated)

Paid-in Capital

¥3,840 million

Net Sales

¥28,384 million

Authorized Outstanding Shares

56,814,093

Number of Shareholders

10,295

(As of March 31, 2019)

LOCATION

Head Office

Marunouchi Center Building 10fl.
6-1, Marunouchi 1-chome, Chiyoda-ku
Tokyo 100-0005, Japan
Tel: (81) 3-5220-8950  
Fax: (81) 3-5220-8951 

Central Research Laboratory ・ CMC Laboratory

1253, Tateno 3-chome, Higashiyamato-shi
Tokyo 207-0021, Japan
Tel: (81) 42-563-5811  
Fax: (81) 42-563-5848 

Kurihama Plant

3-1, Kurihama 9-chome, Yokosuka-shi
Kanagawa 239-0831, Japan
Tel: (81) 46-835-3311  
Fax: (81) 46-834-1918 

Takahagi Plant

258-5, Aza-Matsukubo, Oaza-Akahama
Takahagi-shi, Ibaraki 318-0001, Japan
Tel: (81) 293-23-1181  
Fax: (81) 293-23-7542 

Group Companies

ASSOCIATES OF CAPE COD, INC.

124 Bernard E.Saint Jean Drive, East Falmouth MA 02536, U.S.A
Tel: (1)508-540-3444
Fax: (1)508-540-8680

 

Paid-in Capital:  $2,080million 
Shareholder:  SEIKAGAKU CORPORATION (100%)   
Business:  Manufacturing and sales of endotoxin-detecting reagents